Indicated as monotherapy for Older people with HR-good, HER2-unfavorable Innovative or metastatic breast cancer with disorder progression subsequent endocrine therapy and prior chemotherapy in metastatic environment 200 mg PO BID Take this drugs exactly as directed by your health care provider. Do not consider much more of it, usually do https://joanx111jvf3.blogcudinti.com/profile